0000000001046285

AUTHOR

Birgit Vorndran

showing 2 related works from this author

Intratumoral PO2 Histography as Predictive Assay in Advanced Cancer of the Uterine Cervix

1994

Experimental evidence suggests that the hypoxic fraction in a solid tumor may increase its malignant potential and reduce its sensitivity towards nonsurgical treatment modalities such as standard irradiation and certain anticancer agents1–5. However, the clinical importance of tumor hypoxia remains uncertain since valid methods for the routine measurement of intratumoral O2-tensions in patients have so far been lacking.

Oncologymedicine.medical_specialtyUterine cervixTumor hypoxiabusiness.industryInternal medicinemedicineIn patientTumor OxygenationSolid tumorbusinessAdvanced cancerNonsurgical treatment
researchProduct

Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix.

1993

Abstract Experimental evidence suggests that hypoxia may increase the malignant potential and reduce the sensitivity toward nonsurgical treatment modalities in solid rodent tumors. However, the importance of tumor hypoxia in human malignancies is still uncertain. We have developed a clinically applicable standardized procedure for the determination of intratumoral p O 2 in advanced cervical cancers by use of a computerized polarographic needle electrode histograph. To evaluate the significance of tumor oxygenation as a new oncologic parameter we initiated an open prospective clinical trial at the University of Mainz Medical Center in June 1989. Until October 1992 50 patients with advanced c…

AdultPathologymedicine.medical_specialtymedicine.medical_treatmentBrachytherapyUrologyUterine Cervical NeoplasmsMedicineHumansProspective StudiesElectrodesAgedChemotherapyTumor hypoxiabusiness.industryProportional hazards modelObstetrics and GynecologyOxygenationTumor OxygenationHypoxia (medical)Middle AgedPrognosisCombined Modality TherapyCell HypoxiaRadiation therapyClinical trialOxygenTreatment OutcomeOncologyRegression AnalysisFemalemedicine.symptomRadioisotope TeletherapybusinessGynecologic oncology
researchProduct